Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: A rare condition distinct from blastic plasmacytoid dendritic cell neoplasm

Journal of Cutaneous Pathology

Volumn 38, Issue 11, 2011, Pages 893-898

  Dargent, Jean Louis ^a   Delannoy, André ^b   Pieron, Philippe ^b   Husson, Bernard ^b   Debecker, Caroline ^b   Petrella, Tony ^c  

^a INSTITUTE OF PATHOLOGY AND GENETICS   (Belgium)

^b Centre Hospitalier Jolimont Lobbes   (Belgium)

^c DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

acute myeloid leukemia; blastic plasmacytoid dendritic cell neoplasm; plasmacytoid dendritic cell

Indexed keywords

TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CASE REPORT; DENDRITIC CELL; DERMIS; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; METABOLISM; PATHOLOGY; PLASMA CELL; PLASMACYTOMA; SKIN TUMOR;

AGED; DENDRITIC CELLS; DERMIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; PLASMA CELLS; PLASMACYTOMA; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053574698     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01777.x     Document Type: Article

References (21)

1. Facchetti F, Vermi W, Mason D, Colonna M., The plasmacytoid monocyte/interferon producing cells. Virchows Arch 2003; 443: 703.
2. Marafioti T, Paterson JC, Ballabio E, et al., Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008; 111: 3778.
3. Jegalian AG, Facchetti F, Jaffe ES., Plasmacytoid dendritic cells. Physiologic roles and pathologic states. Adv Anat Pathol 2009; 16: 392.
4. Petrella T, Facchetti F., Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?. Autoimmunity 2010; 43: 210.
5. Wollenberg A, Wagner M, Günther S, et al., Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002; 119: 1096.
6. Charles J, Chaperot L, Salameire D, et al., Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer. Eur J Dermatol 2010; 20: 16.
7. Tomasini D, Mentzel T, Hantschke M, et al., Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner's lymphocytic infiltrate of the skin and cutaneous lupus erythematosus. J Cutan Pathol 2010; 37: 1132.
8. Beiske K, Langholm R, Godal T, Marton PF., T-zone lymphoma with predominance of "plasmacytoid T-cells" associated with myelomonocytic leukaemia-a distinct clinicopathological entity. J Pathol 1986; 150: 247.
9. Thomas JO, Beiske K, Hann I, Koo C, Mason DY., Immunohistochemical diagnosis of "plasmacytoid T cell lymphoma" in paraffin wax sections. J Clin Pathol 1991; 44: 632.
10. Mongkonsritragoon W, Letendre L, Qian J, Li CY., Nodular lesions of monocytic component in myelodysplastic syndrome. Am J Clin Pathol 1998; 110: 154.
11. Chen YC, Chou JM, Ketterling R, Letendre L, Li CY., Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia. Am J Clin Pathol 2003; 120: 874.
12. Vermi W, Facchetti F, Rosati S, et al., Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol 2004; 28: 585.
13. Pileri SA, Ascani S, Cox MC, et al., Myeloid sarcoma: clinicopathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007; 21: 340.
14. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D., TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood 2003; 101: 5007.
15. Muñoz L, Nomdedéu JF, Lõpez O, et al., Interleukin-3 receptor α chain (CD123) is widely expressed in hematologic malignancies. Haematologica 2001; 86: 1261.
16. Facchetti F, Vermi W, Santoro A, Vergoni F, Chilosi M, Doglioni C., Neoplasms derived from plasmacytoid monocytes/interferon-producing cells: variability of CD56 and granzyme B expression. Am J Surg Pathol 2003; 27: 1489.
17. Petrella T, Teitell MA, Spiekermann C, Meijer CJ, Franck F, Enache I., A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol 2004; 150: 174.
18. Kawai K., CD56-negative blastic natural killer-cell lymphoma (agranular CD4(+)/ CD56(+) haematodermic neoplasm). Br J Dermatol 2005; 152: 369.
19. Cota C, Vale E, Viana I, et al., Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm. Morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol 2010; 34: 75.
20. Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D., Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod Pathol 2006; 19: 1555.
21. Mohty M, Jarrossay D, Lafage-Pochitaloff M, et al., Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001; 98: 3750.